Cerebral near-infrared spectroscopy monitoring versus treatment as usual for extremely preterm infants: a protocol for the SafeBoosC randomised clinical phase III trial

BACKGROUND: Cerebral oxygenation monitoring may reduce the risk of death and neurologic complications in extremely preterm infants, but no such effects have yet been demonstrated in preterm infants in sufficiently powered randomised clinical trials. The objective of the SafeBoosC III trial is to inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Hansen, Mathias Lühr, Pellicer, Adelina, Gluud, Christian, Dempsey, Eugene, Mintzer, Jonathan, Hyttel-Sørensen, Simon, Heuchan, Anne Marie, Hagmann, Cornelia, Ergenekon, Ebru, Dimitriou, Gabriel, Pichler, Gerhard, Naulaers, Gunnar, Cheng, Guoqiang, Guimarães, Hercilia, Tkaczyk, Jakub, Kreutzer, Karen B., Fumagalli, Monica, Claris, Olivier, Lemmers, Petra, Fredly, Siv, Szczapa, Tomasz, Austin, Topun, Jakobsen, Janus Christian, Greisen, Gorm
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937938/
https://www.ncbi.nlm.nih.gov/pubmed/31888764
http://dx.doi.org/10.1186/s13063-019-3955-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937938/
https://www.ncbi.nlm.nih.gov/pubmed/31888764
http://dx.doi.org/10.1186/s13063-019-3955-6

Ejemplares similares